Neoadjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Resectable BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria: A Preliminary Report of a Phase III, Randomized, Controlled Clinical Trial

被引：0
|
作者：
Li, S. [1 ]
Wei, W. [1 ]
Wang, Q. [1 ]
Guo, Z. [1 ]
Zou, J. [1 ]
Mei, J. [1 ]
Lu, L. [1 ]
Ling, Y. [1 ]
Xu, L. [1 ]
Chen, M. [1 ]
Lin, W. [1 ]
Wen, Y. [1 ]
Guo, R. [1 ]
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Dept Liver Surg, Guangzhou, Peoples R China
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 17 条
  • [1] Neoadjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria: An interim analysis of a multi-center, phase 3, randomized, controlled clinical trial.
    Li, Shaohua
    Zhong, Chong
    Li, Qiang
    Zou, Jingwen
    Wang, Qiaoxuan
    Shang, Changzhen
    Cheng, Yuan
    Cao, Mingrong
    Huang, Huakun
    Mei, Jie
    Lu, Lianghe
    Zhao, Rongce
    Lin, Wenping
    Wen, Yuhua
    Guo, Zhixing
    Ling, Yihong
    Zheng, Lie
    Wei, Wei
    Guo, Rongping
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Neoadjuvant hepatic arterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria: A multi-center, phase 3, randomized, controlled clinical trial
    Wei, Wei
    Li, Shaohua
    Zhao, Rongce
    Cheng, Yuan
    Li, Qiang
    Lu, Lianghe
    Mei, Jie
    Shang, Changzhen
    Luo, Rui
    Pan, Mingxin
    Xiang, Bangde
    Jiang, Yuchuan
    Lei, Qiucheng
    Cao, Mingrong
    Li, Ji-Bin
    Zheng, Lie
    Chen, Huanwei
    Zhong, Jian-Hong
    Zhong, Chong
    Guo, Rongping
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial
    Shaohua Li
    Jie Mei
    Qiaoxuan Wang
    Zhixing Guo
    Lianghe Lu
    Yihong Ling
    Li Xu
    Minshan Chen
    Lie Zheng
    Wenping Lin
    Jingwen Zou
    Yuhua Wen
    Wei Wei
    Rongping Guo
    Annals of Surgical Oncology, 2020, 27 : 5183 - 5190
  • [4] Postoperative adjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of hepatocellular carcinoma patients with microvascular invasion: A preliminary report of a phase III, randomized, controlled clinical trial
    Li, Shaohua
    Wei, Wei
    Wang, Qiaoxuan
    Guo, Zhixing
    Mei, Jie
    Lu, Lianghe
    Ling, Yihong
    Xu, Li
    Chen, Minshan
    Lin, Wenping
    Zou, Jingwen
    Wen, Yuhua
    Guo, Rongping
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [5] Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial
    Li, Shaohua
    Mei, Jie
    Wang, Qiaoxuan
    Guo, Zhixing
    Lu, Lianghe
    Ling, Yihong
    Xu, Li
    Chen, Minshan
    Zheng, Lie
    Lin, Wenping
    Zou, Jingwen
    Wen, Yuhua
    Wei, Wei
    Guo, Rongping
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (13) : 5183 - 5190
  • [6] Correction to: Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial
    Shaohua Li
    Jie Mei
    Qiaoxuan Wang
    Zhixing Guo
    Lianghe Lu
    Yihong Ling
    Li Xu
    Minshan Chen
    Lie Zheng
    Wenping Lin
    Jingwen Zou
    Yuhua Wen
    Wei Wei
    Rongping Guo
    Annals of Surgical Oncology, 2021, 28 : 874 - 874
  • [7] Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial (vol 27, pg 5183, 2020)
    Li, Shaohua
    Mei, Jie
    Wang, Qiaoxuan
    Guo, Zhixing
    Lu, Lianghe
    Ling, Yihong
    Xu, Li
    Chen, Minshan
    Zheng, Lie
    Lin, Wenping
    Zou, Jingwen
    Wen, Yuhua
    Wei, Wei
    Guo, Rongping
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 3) : 874 - 874
  • [8] Hepatectomy versus transcatheter arterial chemoembolization for resectable BCLC stage A/B hepatocellular carcinoma beyond Milan criteria: A randomized clinical trial
    Fang, Chongkai
    Luo, Rui
    Zhang, Ying
    Wang, Jinan
    Feng, Kunliang
    Liu, Silin
    Chen, Chuyao
    Yao, Ruiwei
    Shi, Hanqian
    Zhong, Chong
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Randomized clinical trial of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization for hepatocellular carcinoma with intermediate stage (BCLC stage B) hepatocellular carcinoma beyond Milan criteria.
    Yin, Xin
    Tang, Bei
    Gan, Yu-Hong
    Wang, Yan-hong
    Chen, Yi
    Ge, Ning-lin
    Chen, Rongxin
    Zhang, Lan
    Zhang, Boheng
    Ren, Zhenggang
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Postoperative adjuvant hepatic arterial infusion chemotherapy (HAIC) with FOLFOX to improve outcomes of patients with hepatocellular carcinoma with microvascular invasion: A prospective multicenter, phase 3, randomized, controlled clinical trial.
    Li, Shaohua
    Mei, Jie
    Cheng, Yuan
    Li, Qiang
    Wang, Qiaoxuan
    Fang, Chongkai
    Lei, Qiucheng
    Huang, Huakun
    Cao, Mingrong
    Luo, Rui
    Deng, Jingduo
    Jiang, Yuchuan
    Zhao, Rongce
    Lu, Lianghe
    Zou, Jingwen
    Zheng, Lie
    Wei, Wei
    Chen, Huanwei
    Zhong, Chong
    Guo, Rongping
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12